Carbon Nanoparticle-Loaded Iron

Tier C — Watch / trade

Originator

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：Not applicable

Indications (approved)：Soft tissue neoplasm, Head and neck squamous cell carcinoma, Lung cancer, Cervical cancer, Thyroid cancer, Colorectal cancer, Solid tumour, 外阴肿瘤

Regional status

China

Phase II

2024-11-12

Japan

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Carbon Nanoparticle-Loaded Iron?

Approved indications include: Soft tissue neoplasm, Head and neck squamous cell carcinoma, Lung cancer, Cervical cancer, Thyroid cancer, Colorectal cancer, Solid tumour, 外阴肿瘤.

When does the Carbon Nanoparticle-Loaded Iron patent expire?

No public expiry year is available for Carbon Nanoparticle-Loaded Iron yet; this page updates once verified.

How do I get a quote for Carbon Nanoparticle-Loaded Iron intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-01